Pervasive developmental disorders (PDDs) are severe developmental disabilities defined by behavioral criteria. Our present understanding of the neurobiological basis of this disorder is limited. Clinicians treating children with PDDs must be aware of the varying severity of manifestations and the lifelong nature of this disorder. The current clinical role of pharmacotherapy in the management of PDDs is to ameliorate behavioral symptoms that are interfering with the individual's ability to participate in educational, social and family systems. In this paper we review some of the medications which have shown positive effects in the treatment of children with PDDs.
|Original language||English (US)|
|Number of pages||8|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health